Stephanie Shaw, MD
Endocrinology, Diabetes & Metabolism · Round Rock, TXNPI 1760687354
Payments from drug & device makers
Across 784 payments — averaging $1193.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$934K
- Novo Nordisk$633
- Lilly USA, LLC$126
- Abbott$107
- Insulet Corporation$76
- Intuitive Surgical$70
- plus $560 from 16 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 673 | $934,286 |
| Novo Nordisk | 66 | $633 |
| Lilly USA, LLC | 7 | $126 |
| Abbott | 7 | $107 |
| Insulet Corporation | 4 | $76 |
| Intuitive Surgical | 1 | $70 |
| BETA Bionics, Inc. | 3 | $68 |
| Ascendis Pharma Endocrinology Inc | 2 | $54 |
| Cequr Corporation | 1 | $53 |
| Amgen | 3 | $51 |
| Medtronic(2 entities) | 2 | $42 |
| Corcept Therapeutics | 2 | $39 |
| IBSA Pharma Inc. | 2 | $36 |
| Tandem Diabetes Care, Inc. | 3 | $32 |
| Ascensia Diabetes Care US Inc. | 1 | $31 |
| Rhythm Pharmaceuticals, Inc. | 1 | $29 |
| Acella Pharmaceuticals, LLC | 1 | $29 |
| Amneal Pharmaceuticals LLC | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Sequel Med Tech, LLC | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
How this compares
$935,858 in reported general payments places this provider in the 90th percentile of 658 endocrinology, diabetes & metabolism providers in Texas.
See all endocrinology, diabetes & metabolism providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Round Rock
- Hien TranRound Rock$3.6M
- Kerem OzerRound Rock$2.3M
- Julio RosenstockDallas$24.9M
- Michelle WelchShavano Park$17.3M
- Maria CabanillasHouston$16.4M
- Sumana GangiMesquite$13.2M
- Damaris VegaHouston$12.3M
- Mark KipnesSan Antonio$10.3M
- Amer Al KaradshehHouston$8.8M
- Ildiko LingvayDallas$8.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.